Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat... Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treatments that address underlying dysfunctions in neuronal signaling, aiming to improve the quality of life for patients suffering from these conditions. The company is a significant player in the healthcare sector, particularly impacting the psychiatric and neurological segments. Through research and development, it creates therapies that target specific mechanisms within brain cells, offering potential breakthroughs in understanding and treating mental health issues. With a commitment to transforming patient care, Intra-Cellular Therapies Inc. contributes to the pharmaceutical landscape by providing new and effective treatment options. Its work not only addresses clinical needs but also has the potential to drive advancements in medical science, thereby holding a vital role in the intersection of medical research and practical healthcare solutions.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Intra-Cellular Therapies

We reviewed Intra-Cellular Therapies's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Intra-Cellular Therapies's data?

Create a free Tracenable account to signal interest in having our team review data for Intra-Cellular Therapies.

Legal Center Contact Us